吸烟及戒烟对大鼠血清瘦素、脂联素等炎症因子水平的影响
|
摘要
目的通过研究不同吸烟量及戒烟对大鼠血清瘦素、脂联素、白细胞介素(interleukinIL)-6及C反应蛋白(C-reactive protein CRP)水平的影响,探讨瘦素、脂联素等炎症因子在吸烟所致COPD全身炎症反应中的作用。
方法8周龄健康雄性Wistar大鼠(山西医科大学实验动物中心提供)32只,体重(200±20)g,随机分为健康对照组、大量吸烟组、小量吸烟组、大量吸烟后戒烟组,每组各8只。参照许三林等自制实验性大鼠被动吸烟装置,大量组每天吸烟2次(上、下午各一次),每次吸烟10支,大约两个小时,每周吸烟6天,共吸烟20周。小量组每天吸烟2次,每次吸烟5支,大约一小时,每周吸烟6天,共吸烟20周。戒烟组每天吸烟2次,每次吸烟10支,共吸烟20周后,脱离吸烟环境10周。采用双抗体夹心酶联免疫吸附法(ABC-ELISA)分别检测血清瘦素、脂联素、IL-6及CRP水平。
结果
1.瘦素
与对照组[(128.00±13.25) pg/ml]比较,大量吸烟组和小量吸烟组及戒烟组[分别为(56.23±8.64) pg/ml; (64.13±10.36) pg/ml; (60.36±7.42) pg/ml]血清水平均降低(P均<0.05)；大量吸烟组与小量吸烟组及戒烟组相比,差异均无统计学意义。
2.脂联素
与对照组[(0.369±0.032) ng/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(0.322±0.045) ng/ml]; (0.327±0.024) ng/ml; (0.333±0.059) ng/ml]血清水平均降低(P均<0.05)；大量吸烟组与小量吸烟组及戒烟组相比,差异均无统计学意义。
3.IL-6
与对照组[(32.71±2.86) pg/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(39.67±3.13) pg/ml; (36.58±2.43) pg/ml; (34.27±7.01) pg/ml]血清水平均升高(P均<0.05)；大量吸烟组较小量吸烟组及戒烟组水平高(P均<0.05)。
4.CRP
与对照组[(494.49±124.44) ng/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(809.50±141.66) ng/ml; (628.91±128.83) ng/ml; (642.60±180.55) ng/ml]血清水平均升高(P均<0.05)；大量吸烟组较小量吸烟组及戒烟水平高(P均<0.05)。
5.相关性分析
脂联素水平分别与IL-6和CRP呈负相关(分别为r=-0.392,P<0.01；r=-0.631,P<0.05)。
结论吸烟可使大鼠血清瘦素与脂联素水平下降；IL-6与CRP水平升高,并且随着吸烟量的增加,IL-6及CRP水平进一步增加；戒烟后,瘦素与脂联素水平无明显变化,仍低于对照组,IL-6与CRP水平明显下降,但仍高于对照组；脂联素水平分别与IL-6和CRP呈负相关；以上结果提示瘦素、脂联素等炎症因子参与吸烟所致COPD的全身炎症反应。
Objective:The objective of this paper is to investigate the role of inflammatory factors like serum leptin, adiponectin, interleukin-6 (IL-6) and C-reactive protein (CRP) in the systemic inflammatory response of smoking-induced COPD.
Methods:32 Male Wistar rats are randomly divided into four groups:group of rats smoking heavily, group of rats smoking fewer, group of rats smoke abatement and a control group, with 8 rats for each group. Rat smoking device was in accordance with Xusanlin smoking device.Except the rats of the control group, all the other rats smoke 2 times one day,6 days one week, for 20 weeks.The first group and the third group smoke 10 cigarettes each time, while the second group 5. The third group of rats quit smoking for 10 weeks after smoking 20 weeks. Serum leptin, adiponectin, IL-6 and CRP levels are measured by ABC-enzyme-linked immunosorbent assay(ELISA).
Results:
1. Leptin:Compared to the control group[(128.00±13.25)pg/ml], serum leptin levels of the rats in the other three groups [(56.23±8.64) pg/ml; (64.13±10.36) pg/ml; (60.36±7.42) pg/ml respectively] decrease significantly (all P<0.05); compared to the first group, the difference is not significant in both the second group and the third group (P> 0.05 respectively)
2. Adiponectin:Compared to the control group[(0.369±0.032) ng/ml], serum adiponectin levels of the rats in the other three groups[(0.322±0.045) ng/ml; (0.327±0.024) ng/ml; (0.333±0.059) ng/ml; respectively] decrease significantly (all P<0.05); compared to the first group, the difference is not significant in both the second group and the third group (P> 0.05 respectively)
3. IL-6:Compared to the control group, serum IL-6 levels of the rats in the other three groups[(39.67±3.13) pg/ml; (36.58±2.43) pg/ml; (34.27±7.01) pg/ml respectively] increase significantly (all P<0.05); serum IL-6 levels of the rats in the second group and the third group are lower than those of the first group (P<0.05 respectively)
4. CRP:Compared to the control group, serum CRP levels of the rats in the other three groups [(809.50±141.66) ng/ml; (628.91±128.83) ng/ml; (642.60±180.55) ng/ml respectively] increase significantly (all P<0.05); serum CRP levels of the rats in both second group and the third group are lower than those of the first group (P<0.05 respectively)
5. Correlation Analysis:Adiponectin levels are inversely related with IL-6 and CRP (r=-0.392, P＜0.01; r=-0.631, P＜0.05 respectively)
Conclusions Smoking reduces the levels of serum leptin and adiponectin but increases the levels of serum IL-6 and CRP of rats, further more, serum IL-6 and CRP levels are positively related with smoking status. After smoke quitting, levels of serum leptin and adiponectin are still lower than those fo the control group, while IL-6 and CRP levels decrease, but both of them are higher than those of the control group. What's more, adiponectin level is inversely related with IL-6 and CRP. These results suggest that inflammatory factors such as leptin, adiponectin be involved in the systemic inflammatory response of smoking-induced COPD.
方法8周龄健康雄性Wistar大鼠(山西医科大学实验动物中心提供)32只,体重(200±20)g,随机分为健康对照组、大量吸烟组、小量吸烟组、大量吸烟后戒烟组,每组各8只。参照许三林等自制实验性大鼠被动吸烟装置,大量组每天吸烟2次(上、下午各一次),每次吸烟10支,大约两个小时,每周吸烟6天,共吸烟20周。小量组每天吸烟2次,每次吸烟5支,大约一小时,每周吸烟6天,共吸烟20周。戒烟组每天吸烟2次,每次吸烟10支,共吸烟20周后,脱离吸烟环境10周。采用双抗体夹心酶联免疫吸附法(ABC-ELISA)分别检测血清瘦素、脂联素、IL-6及CRP水平。
结果
1.瘦素
与对照组[(128.00±13.25) pg/ml]比较,大量吸烟组和小量吸烟组及戒烟组[分别为(56.23±8.64) pg/ml; (64.13±10.36) pg/ml; (60.36±7.42) pg/ml]血清水平均降低(P均<0.05)；大量吸烟组与小量吸烟组及戒烟组相比,差异均无统计学意义。
2.脂联素
与对照组[(0.369±0.032) ng/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(0.322±0.045) ng/ml]; (0.327±0.024) ng/ml; (0.333±0.059) ng/ml]血清水平均降低(P均<0.05)；大量吸烟组与小量吸烟组及戒烟组相比,差异均无统计学意义。
3.IL-6
与对照组[(32.71±2.86) pg/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(39.67±3.13) pg/ml; (36.58±2.43) pg/ml; (34.27±7.01) pg/ml]血清水平均升高(P均<0.05)；大量吸烟组较小量吸烟组及戒烟组水平高(P均<0.05)。
4.CRP
与对照组[(494.49±124.44) ng/ml]比较,大量吸烟组、小量吸烟组及戒烟组[分别为(809.50±141.66) ng/ml; (628.91±128.83) ng/ml; (642.60±180.55) ng/ml]血清水平均升高(P均<0.05)；大量吸烟组较小量吸烟组及戒烟水平高(P均<0.05)。
5.相关性分析
脂联素水平分别与IL-6和CRP呈负相关(分别为r=-0.392,P<0.01；r=-0.631,P<0.05)。
结论吸烟可使大鼠血清瘦素与脂联素水平下降；IL-6与CRP水平升高,并且随着吸烟量的增加,IL-6及CRP水平进一步增加；戒烟后,瘦素与脂联素水平无明显变化,仍低于对照组,IL-6与CRP水平明显下降,但仍高于对照组；脂联素水平分别与IL-6和CRP呈负相关；以上结果提示瘦素、脂联素等炎症因子参与吸烟所致COPD的全身炎症反应。
Objective:The objective of this paper is to investigate the role of inflammatory factors like serum leptin, adiponectin, interleukin-6 (IL-6) and C-reactive protein (CRP) in the systemic inflammatory response of smoking-induced COPD.
Methods:32 Male Wistar rats are randomly divided into four groups:group of rats smoking heavily, group of rats smoking fewer, group of rats smoke abatement and a control group, with 8 rats for each group. Rat smoking device was in accordance with Xusanlin smoking device.Except the rats of the control group, all the other rats smoke 2 times one day,6 days one week, for 20 weeks.The first group and the third group smoke 10 cigarettes each time, while the second group 5. The third group of rats quit smoking for 10 weeks after smoking 20 weeks. Serum leptin, adiponectin, IL-6 and CRP levels are measured by ABC-enzyme-linked immunosorbent assay(ELISA).
Results:
1. Leptin:Compared to the control group[(128.00±13.25)pg/ml], serum leptin levels of the rats in the other three groups [(56.23±8.64) pg/ml; (64.13±10.36) pg/ml; (60.36±7.42) pg/ml respectively] decrease significantly (all P<0.05); compared to the first group, the difference is not significant in both the second group and the third group (P> 0.05 respectively)
2. Adiponectin:Compared to the control group[(0.369±0.032) ng/ml], serum adiponectin levels of the rats in the other three groups[(0.322±0.045) ng/ml; (0.327±0.024) ng/ml; (0.333±0.059) ng/ml; respectively] decrease significantly (all P<0.05); compared to the first group, the difference is not significant in both the second group and the third group (P> 0.05 respectively)
3. IL-6:Compared to the control group, serum IL-6 levels of the rats in the other three groups[(39.67±3.13) pg/ml; (36.58±2.43) pg/ml; (34.27±7.01) pg/ml respectively] increase significantly (all P<0.05); serum IL-6 levels of the rats in the second group and the third group are lower than those of the first group (P<0.05 respectively)
4. CRP:Compared to the control group, serum CRP levels of the rats in the other three groups [(809.50±141.66) ng/ml; (628.91±128.83) ng/ml; (642.60±180.55) ng/ml respectively] increase significantly (all P<0.05); serum CRP levels of the rats in both second group and the third group are lower than those of the first group (P<0.05 respectively)
5. Correlation Analysis:Adiponectin levels are inversely related with IL-6 and CRP (r=-0.392, P＜0.01; r=-0.631, P＜0.05 respectively)
Conclusions Smoking reduces the levels of serum leptin and adiponectin but increases the levels of serum IL-6 and CRP of rats, further more, serum IL-6 and CRP levels are positively related with smoking status. After smoke quitting, levels of serum leptin and adiponectin are still lower than those fo the control group, while IL-6 and CRP levels decrease, but both of them are higher than those of the control group. What's more, adiponectin level is inversely related with IL-6 and CRP. These results suggest that inflammatory factors such as leptin, adiponectin be involved in the systemic inflammatory response of smoking-induced COPD.
引文
[1]van Weel C, Schellevis FG. Comorbidity and guidelines:conflicting interests. Lancet,2006,367: 550-551
[2]Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD:role of comorbidities. Eur Respir J,2006, 28:1245-1257
[3]Terashima T, Wiggs B, English D, et al. Phagocytosis of small carbon particles by alveolar macrophages stimulates the release of PMN from the bone marrow. Am J Respir Crit Care Med.1997,155:1441-1447
[4]Terashima T, Klut ME, English D, et al. Chronic cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in pulmonary capillaries. Am J Respir Cell Mol Biol.1998,20:171-177
[5]Schols AM, Creutzerg EC, Buurman WA, et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1999,160: 1220-1226
[6]Kirdar S, Serter M, Ceylan E, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest,2009,69:219-224
[7]Otero M, Lago F. Leptin, from fat to inflammation:old questions and new insights. FEB S Lett,2005,579: 295-301
[8]Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol,2005,115:911-919
[9]Vernooy JH, Drummen NE. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax,2009,64(1):26-32
[10]Marina Miller, Jae Youn Cho. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009,182(1):684-91
[11]许三林,吴人亮,陈春莲,等.上皮钙黏附素在吸烟小鼠呼吸道上皮损伤修复中表达的研究.中华结核和呼吸杂志,1999,22：417-419
[12]Kirchgessner TG, Uysal KT, Wiesbrock SM, et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest,1997,100 2777-2782
[13]Trujillo ME, Sullivan S, Harten I, et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab,2004,89:5577-5582
[14]Sull JW, Kim HJ, Yun JE, et al. Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J,2009,56:73-78
[15]Gettys TW, Harkness PJ, Waston PM. The (33-aderenergic receptor inhibits insulin-stinulated leptin secretion from isolated rat adipocytes. Endocrinology,1996,137:4054-4057
[16]Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines:in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab,2003,285:E527-533
[17]Iwashima Y, Katauya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension,2005,45:1094-1100
[18]Pepys MB,Hirschfield GM. C-reactive protein:a critical update. J Clin Invest,2003,111:1805-1812
[1]Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001,163:1256-1276
[2]Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD:role of comorbidities. Eur Respir J 2006,28:1245-1257
[3]Zhang Y, Proenca R, Maffei M, et al. Positional Cloning of the Mouse Obese Gene and It s Human Homologue. Nature,1994,372:425-432
[4]Cammisotto P G, Bukowiecki L J. Mechanisms of Leptin Secre2tion from White Adipocytes. Am J Physiol Cell Physiol,2002,283:C244-C250
[5]McDuffie I A, Akhter N, Childs G V. Regulation of Leptin mRNA and Protein Expression in Pituitary Somatot-ropes. J Histochem Cytochem,2004,52:263-273
[6]Sahu A. Minireview:A Hypot halamic Role in Energy Balance with Special Emphasis on Leptin. Endocrinology,2004,145:2613-2620
[7]Smit h J T, Waddell B J. Leptin Receptor Expression in the Rat Placenta:Changes in ob-Ra, ob-Rb, and ob-Re with Gestational Age and Suppression by Glucocorticoids. Biol Peprod,2002,67:1204-1210
[8]Bergen H T, Cherlet T C, Manuel P, et al. Identification of Leptin Receptors in Lung and Isolated Fetal Type Ⅱ Cells. Am J Respir Cell Mol Biol,2002,27:71-77
[9]Cohen P, Yang G Q, Yu X X, et al. Induction of Receptor Expression in t he Liver by Leptin and Food Deprivation. J Biol Chem,2005,280:10034-10039
[10]刘玲,况九龙.瘦素与慢性阻塞性肺疾病的关系.实用临床医学,2008,9(1)：131-133
[11]Scherer PE, Walliams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem,1995,270:26746-26749
[12]Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA.2001,98:2005-2010
[13]Zhang Y. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta,2002,1584: 115-122
[14]Yoda-Murakami M, Taniguchi M, Takahashi K, et al. Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochem Biophys Res Commun,2001,285:372-377
[15]Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut, 2005,54:117-121
[16]Delaigle AM, Jonas JC, Bauche IB, et al. Induction of adiponectin in skeletal muscle by inflammatory cytokines:in vivo and in vitro studies. Endocrinology,2004,145:5589-5597
[17]Shinoda Y, Yamaguchi M, Ogata N, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem,2006,99:196-208
[18]Marina Miller, Jae Youn Cho. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009,182(1):684-691
[19]王芳,顾鸣敏,王铸钢.脂联素的研究进展.现代生物医学进展,2008,8：1549-1552
[20]Foley RJ, Zu Wallack R. The impact of nutritional depletion in chronic obstructive pulmonary disease. J Cardiopulm Rehabil,2001,21:288-295
[21]Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1999,160:1856-1861
[22]Zumbach MS, Boehme MW, Wahl P, et al. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab,1997,82:4080-4082
[23]Calikoglu M, Sahin G, Unlu A, et al. Leptin and TNF-alpha Levels in Patient s wit h Chronic Obstructive Pulmonary Disease and Their Relationship to Nut ritional Parameters. Respiration,2004,71:45-50
[24]Calikoglu M, Sahin G, Unlu A, et al. Leptin and TNF-alpha Levels in Patients with Chronic Obstructive Pulmonary Disease and Their Relationship to Nutritional Parameters. Respiration,2004,71:45-50
[25]农英,林江涛.慢性阻塞性肺疾病急性加重期饮食摄入与血清瘦素及全身炎症状态关系的研究.国际呼吸杂志,2006,3：161-163
[26]Sweeney G, Keen J, Somwar R, et al. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in 16 rat skeletal muscle cells. Endocrinology 2005, 142(11):4806-4812
[27]Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality:a population-based study and a systematic review of the literature. Chest 2005,127:1952-1959
[28]Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 1994,272: 1497-150
[29]Wise RA, McGarvey LP, John M, et al. Reliability of cause-specific mortality adjudication in COPD clinical trial. Proc Am Thorac Soc,2006,3:A120
[30]Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein,inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation.2000,102:1296-1301
[31]Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation.2004,110 (10):1269-1275
[32]Tamer L, Ercan B, Unlu A, et al. The relationship between leptin and lipids in atherosclerosis. Indian Heart,2002,54:692-696
[33]Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med,2003,114:10-14
[34]Reseland JE, Syversen U, Bakke I, et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. BoneMiner Res,2001,16(8):1426-1433
[35]Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology,1999,140(4):1630-1638
[36]李双庆,赵红莉,魏松全,等.人成骨细胞瘦素受体放射配基结合分析研究.华西医科大学学报,2002,33,375-378
[37]Goldstone AP, Howard JK, Lord GM, et al. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun,2002,295:475-481
[38]Shinoda Y, Yamaguchi M. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.J Cell Biochem,2006,99:196-208
[39]Goldstone AP, Howard JK, Lord GM, et al. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun,2002,295 (2):475-481
[40]Sin DD, Man JP, Man SF. The risk of osteoporosisin Caucasian men and women with obstructive airways disease. Am J Med 2003,114:10-14
[41]Yusuke Shinoda, Masayuki Yamaguchi, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. Cell Biochem,2006,99:196-208
[42]Sevin Krdar, Mukadder Serter, Emel Ceylan c, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary Disease. Scand Clin Lab Invest.2008,22:1-6
[43]Koichi Tomoda, Masanori Yoshikawa. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest,2007,132(1):135-140
[44]Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care,2004,27:2478-2484
[45]Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study. Diabetes 2001,50:2384-2389
[46]Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study):a cohort study. Lancet,1999,353:1649-1652
[47]Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997,40: 1286-1292
[48]Zinman B, Hanley AJ, Harris SB, et al. Circulating tumor necrosis factor-_ concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999,84:272-278
[49]Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res,2004,12:180-186
[50]Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation,2000,102:1296-1301
[51]Kennedy A, Gettys TW, Watson P, et al. The metabolic significance of leptin in humans:gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Clin Endocrinol Metab,1997,82(4):1293-1300
[52]周鹏,朱大龙,何戎华等.瘦素与胰岛素抵抗及糖代谢异常的关系.中华内分泌杂志,2002,18(4)：305-306
[53]Unger RH, Zhou YT. Lipotoxicity of β-cell in obesity in other causes of fatty acid spillover. Diabetes. 2001,50:S118-S121
[54]Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis,2008,5(1):35-41
[55]Otero M, Lago F. Leptin, from fat to inflammation:old questions and new insights. FEB S Lett,2005,579: 295-301
[56]Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol,2005,115:911-919
[57]Broekhuizen R, Vernooy JH, Schol s AM, et al. Leptin as Local Inflammatory Marker in Chronic Obstructive Pulmonary Disease. Respir Med,2005,99:70-74
[58]吴秀明,李继红,李春梅.瘦素在慢性阻塞性肺疾病患者诱导痰中的变化及意义.中国现代医学杂志,2007,15：1897-1899
[59]A. Bruno, P.Chanez, GChiappara, et al. Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J,2005,26:398-405
[60]Vernooy JH, Drummen NE. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax,2009,64(1):26-32
[61]Joo Hwa Shin, Jung Ho Kim. The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells. Yonsei Med J,2008,49(5):804-810
[62]Summer. R., F. Little, N. Ouchi, et al. Alveolar macrophages activation and an emphysema-like phenotype in adiponectin deficient mice. Am. J. Physiol,2008,294:L1035-L1042
[63]Terashima T, Wiggs B, English D, et al. Phagocytosis of small carbon particles by alveolar macrophages stimulates the release of PMN from the bone marrow.Am J Respir Crit Care Med,1997,155:1441-1447
[64]Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality:a population-based study and a systematic review of the literature. Chest,2005,127:1952-1959
[65]Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. Cardiovasc Med (Hagerstown),2007,8: 253-257
[66]Landbo C, Prescott E, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1999,160:1856-1861
[67]潘海燕,卢小卓,汪得喜等.C反应蛋白与瘦素对慢性阻塞性肺疾病患者病情严重程度的评估价值.中国临床康复,2005,9(31)：74-75
[68]Sin DD, Man S F P. Impaired Lung Function and Serum Leptin in Men and Women with Normal Body Weight:a Population Based Study. Thorax,2003,58:695-698
[69]Hansel NN, Gao L, Rafaels NM, et al. Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J.2009,34(1):103-110
[2]Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD:role of comorbidities. Eur Respir J,2006, 28:1245-1257
[3]Terashima T, Wiggs B, English D, et al. Phagocytosis of small carbon particles by alveolar macrophages stimulates the release of PMN from the bone marrow. Am J Respir Crit Care Med.1997,155:1441-1447
[4]Terashima T, Klut ME, English D, et al. Chronic cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in pulmonary capillaries. Am J Respir Cell Mol Biol.1998,20:171-177
[5]Schols AM, Creutzerg EC, Buurman WA, et al. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1999,160: 1220-1226
[6]Kirdar S, Serter M, Ceylan E, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest,2009,69:219-224
[7]Otero M, Lago F. Leptin, from fat to inflammation:old questions and new insights. FEB S Lett,2005,579: 295-301
[8]Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol,2005,115:911-919
[9]Vernooy JH, Drummen NE. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax,2009,64(1):26-32
[10]Marina Miller, Jae Youn Cho. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009,182(1):684-91
[11]许三林,吴人亮,陈春莲,等.上皮钙黏附素在吸烟小鼠呼吸道上皮损伤修复中表达的研究.中华结核和呼吸杂志,1999,22：417-419
[12]Kirchgessner TG, Uysal KT, Wiesbrock SM, et al. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest,1997,100 2777-2782
[13]Trujillo ME, Sullivan S, Harten I, et al. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab,2004,89:5577-5582
[14]Sull JW, Kim HJ, Yun JE, et al. Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J,2009,56:73-78
[15]Gettys TW, Harkness PJ, Waston PM. The (33-aderenergic receptor inhibits insulin-stinulated leptin secretion from isolated rat adipocytes. Endocrinology,1996,137:4054-4057
[16]Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines:in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab,2003,285:E527-533
[17]Iwashima Y, Katauya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension,2005,45:1094-1100
[18]Pepys MB,Hirschfield GM. C-reactive protein:a critical update. J Clin Invest,2003,111:1805-1812
[1]Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001,163:1256-1276
[2]Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD:role of comorbidities. Eur Respir J 2006,28:1245-1257
[3]Zhang Y, Proenca R, Maffei M, et al. Positional Cloning of the Mouse Obese Gene and It s Human Homologue. Nature,1994,372:425-432
[4]Cammisotto P G, Bukowiecki L J. Mechanisms of Leptin Secre2tion from White Adipocytes. Am J Physiol Cell Physiol,2002,283:C244-C250
[5]McDuffie I A, Akhter N, Childs G V. Regulation of Leptin mRNA and Protein Expression in Pituitary Somatot-ropes. J Histochem Cytochem,2004,52:263-273
[6]Sahu A. Minireview:A Hypot halamic Role in Energy Balance with Special Emphasis on Leptin. Endocrinology,2004,145:2613-2620
[7]Smit h J T, Waddell B J. Leptin Receptor Expression in the Rat Placenta:Changes in ob-Ra, ob-Rb, and ob-Re with Gestational Age and Suppression by Glucocorticoids. Biol Peprod,2002,67:1204-1210
[8]Bergen H T, Cherlet T C, Manuel P, et al. Identification of Leptin Receptors in Lung and Isolated Fetal Type Ⅱ Cells. Am J Respir Cell Mol Biol,2002,27:71-77
[9]Cohen P, Yang G Q, Yu X X, et al. Induction of Receptor Expression in t he Liver by Leptin and Food Deprivation. J Biol Chem,2005,280:10034-10039
[10]刘玲,况九龙.瘦素与慢性阻塞性肺疾病的关系.实用临床医学,2008,9(1)：131-133
[11]Scherer PE, Walliams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem,1995,270:26746-26749
[12]Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA.2001,98:2005-2010
[13]Zhang Y. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta,2002,1584: 115-122
[14]Yoda-Murakami M, Taniguchi M, Takahashi K, et al. Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver. Biochem Biophys Res Commun,2001,285:372-377
[15]Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut, 2005,54:117-121
[16]Delaigle AM, Jonas JC, Bauche IB, et al. Induction of adiponectin in skeletal muscle by inflammatory cytokines:in vivo and in vitro studies. Endocrinology,2004,145:5589-5597
[17]Shinoda Y, Yamaguchi M, Ogata N, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem,2006,99:196-208
[18]Marina Miller, Jae Youn Cho. Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol 2009,182(1):684-691
[19]王芳,顾鸣敏,王铸钢.脂联素的研究进展.现代生物医学进展,2008,8：1549-1552
[20]Foley RJ, Zu Wallack R. The impact of nutritional depletion in chronic obstructive pulmonary disease. J Cardiopulm Rehabil,2001,21:288-295
[21]Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,1999,160:1856-1861
[22]Zumbach MS, Boehme MW, Wahl P, et al. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab,1997,82:4080-4082
[23]Calikoglu M, Sahin G, Unlu A, et al. Leptin and TNF-alpha Levels in Patient s wit h Chronic Obstructive Pulmonary Disease and Their Relationship to Nut ritional Parameters. Respiration,2004,71:45-50
[24]Calikoglu M, Sahin G, Unlu A, et al. Leptin and TNF-alpha Levels in Patients with Chronic Obstructive Pulmonary Disease and Their Relationship to Nutritional Parameters. Respiration,2004,71:45-50
[25]农英,林江涛.慢性阻塞性肺疾病急性加重期饮食摄入与血清瘦素及全身炎症状态关系的研究.国际呼吸杂志,2006,3：161-163
[26]Sweeney G, Keen J, Somwar R, et al. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in 16 rat skeletal muscle cells. Endocrinology 2005, 142(11):4806-4812
[27]Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality:a population-based study and a systematic review of the literature. Chest 2005,127:1952-1959
[28]Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 1994,272: 1497-150
[29]Wise RA, McGarvey LP, John M, et al. Reliability of cause-specific mortality adjudication in COPD clinical trial. Proc Am Thorac Soc,2006,3:A120
[30]Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocyte-derived plasma protein,inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation.2000,102:1296-1301
[31]Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation.2004,110 (10):1269-1275
[32]Tamer L, Ercan B, Unlu A, et al. The relationship between leptin and lipids in atherosclerosis. Indian Heart,2002,54:692-696
[33]Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med,2003,114:10-14
[34]Reseland JE, Syversen U, Bakke I, et al. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. BoneMiner Res,2001,16(8):1426-1433
[35]Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology,1999,140(4):1630-1638
[36]李双庆,赵红莉,魏松全,等.人成骨细胞瘦素受体放射配基结合分析研究.华西医科大学学报,2002,33,375-378
[37]Goldstone AP, Howard JK, Lord GM, et al. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun,2002,295:475-481
[38]Shinoda Y, Yamaguchi M. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.J Cell Biochem,2006,99:196-208
[39]Goldstone AP, Howard JK, Lord GM, et al. Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun,2002,295 (2):475-481
[40]Sin DD, Man JP, Man SF. The risk of osteoporosisin Caucasian men and women with obstructive airways disease. Am J Med 2003,114:10-14
[41]Yusuke Shinoda, Masayuki Yamaguchi, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. Cell Biochem,2006,99:196-208
[42]Sevin Krdar, Mukadder Serter, Emel Ceylan c, et al. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary Disease. Scand Clin Lab Invest.2008,22:1-6
[43]Koichi Tomoda, Masanori Yoshikawa. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest,2007,132(1):135-140
[44]Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care,2004,27:2478-2484
[45]Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study. Diabetes 2001,50:2384-2389
[46]Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study):a cohort study. Lancet,1999,353:1649-1652
[47]Pickup JC, Mattock MB, Chusney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997,40: 1286-1292
[48]Zinman B, Hanley AJ, Harris SB, et al. Circulating tumor necrosis factor-_ concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999,84:272-278
[49]Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res,2004,12:180-186
[50]Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation,2000,102:1296-1301
[51]Kennedy A, Gettys TW, Watson P, et al. The metabolic significance of leptin in humans:gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Clin Endocrinol Metab,1997,82(4):1293-1300
[52]周鹏,朱大龙,何戎华等.瘦素与胰岛素抵抗及糖代谢异常的关系.中华内分泌杂志,2002,18(4)：305-306
[53]Unger RH, Zhou YT. Lipotoxicity of β-cell in obesity in other causes of fatty acid spillover. Diabetes. 2001,50:S118-S121
[54]Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis,2008,5(1):35-41
[55]Otero M, Lago F. Leptin, from fat to inflammation:old questions and new insights. FEB S Lett,2005,579: 295-301
[56]Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol,2005,115:911-919
[57]Broekhuizen R, Vernooy JH, Schol s AM, et al. Leptin as Local Inflammatory Marker in Chronic Obstructive Pulmonary Disease. Respir Med,2005,99:70-74
[58]吴秀明,李继红,李春梅.瘦素在慢性阻塞性肺疾病患者诱导痰中的变化及意义.中国现代医学杂志,2007,15：1897-1899
[59]A. Bruno, P.Chanez, GChiappara, et al. Does leptin play a cytokine-like role within the airways of COPD patients? Eur Respir J,2005,26:398-405
[60]Vernooy JH, Drummen NE. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax,2009,64(1):26-32
[61]Joo Hwa Shin, Jung Ho Kim. The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells. Yonsei Med J,2008,49(5):804-810
[62]Summer. R., F. Little, N. Ouchi, et al. Alveolar macrophages activation and an emphysema-like phenotype in adiponectin deficient mice. Am. J. Physiol,2008,294:L1035-L1042
[63]Terashima T, Wiggs B, English D, et al. Phagocytosis of small carbon particles by alveolar macrophages stimulates the release of PMN from the bone marrow.Am J Respir Crit Care Med,1997,155:1441-1447
[64]Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality:a population-based study and a systematic review of the literature. Chest,2005,127:1952-1959
[65]Stein PD, Beemath A, Meyers FA, et al. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. Cardiovasc Med (Hagerstown),2007,8: 253-257
[66]Landbo C, Prescott E, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1999,160:1856-1861
[67]潘海燕,卢小卓,汪得喜等.C反应蛋白与瘦素对慢性阻塞性肺疾病患者病情严重程度的评估价值.中国临床康复,2005,9(31)：74-75
[68]Sin DD, Man S F P. Impaired Lung Function and Serum Leptin in Men and Women with Normal Body Weight:a Population Based Study. Thorax,2003,58:695-698
[69]Hansel NN, Gao L, Rafaels NM, et al. Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J.2009,34(1):103-110